Outlook Therapeutics Incs. (OTLK) PT Raised to $13 at Brookline Capital Markets
Tweet Send to a Friend
Brookline Capital Markets analyst Kemp Dolliver raised the price target on Outlook Therapeutics Incs. (NASDAQ: OTLK) to $13.00 (from $8.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
